https://www.cgtlive.com/view/european-commission-approves-janssen-legend-biotech-carvykti-expanded-indication-earlier-line-multiple-myeloma
European Commission Approves Janssen and Legend Biotech’s Carvykti for Expanded Indication in...
Oct 9, 2026 - The EC’s decision comes several weeks after the FDA approved cilta-cel for a similar expanded indication.
european commissionapprovesjanssenlegendcarvykti
https://www.biotechtv.com/post/legend-biotech-ash-2025
ASH 2025: Legend Biotech CEO Ying Huang discusses new long-term Carvykti data, looming competition,...
Dec 6, 2025 - He says he is confident in the commercial leadership profile that Carvykti has established, and walks us through potential follow-on pipeline programs.
ying huanglong termashlegendbiotech
https://www.aboutlawsuits.com/topics/carvykti/
Carvykti Archives - AboutLawsuits.com
carvyktiarchives
https://www.booklaunchexpress.com/article/945152621-legend-biotech-presents-carvykti-data-showing-half-of-patients-with-rrmm-remained-progression-free-and-alive-five-years-after-a-single-infusion
Legend Biotech Presents CARVYKTI Data Showing Half of Patients with RRMM Remained Progression-Free...
legendbiotechpresentscarvyktidata